• Home
  • about
  • contact
  • twitter
  • archive
  • RSS

Stem Cell Assays

RegenMed

Cell product development – academic versus industry model

by Alexey Bersenev on February 20, 2012 · 0 comments

in RegenMed digest

10 companies to watch in 2012

by Alexey Bersenev on January 27, 2012 · 0 comments

in RegenMed digest

Public cell therapy and stem cell companies in 2011

by Alexey Bersenev on January 8, 2012 · 3 comments

in RegenMed digest

Regenerative medicine and cell therapy industry in 2011

by Alexey Bersenev on December 29, 2011 · 2 comments

in RegenMed digest

Distinction between cell therapy and regenerative medicine

by Alexey Bersenev on December 12, 2011 · 0 comments

in RegenMed digest

Is FDA slowing down the progress in clinical cell therapy?

by Alexey Bersenev on November 27, 2011 · 1 comment

in cell product,RegenMed digest

Educational resources for cell therapy professionals

by Alexey Bersenev on November 21, 2011 · 0 comments

in cell product,educational,RegenMed digest

Regenerative medicine industry – worthwhile investment or not?

by Alexey Bersenev on September 6, 2011 · 0 comments

in RegenMed digest

Regenerative medicine progress in regions

by Alexey Bersenev on August 15, 2011 · 2 comments

in RegenMed digest

Recent notable approvals in regenerative medicine

by Alexey Bersenev on July 25, 2011 · 1 comment

in RegenMed digest

← Previous Entries

  • search

  • follow updates:

    • subscribe via RSS
    • Enter your email address:

  • advertisement

  • our partners:

  • categories

    • adipose (6)
    • cancer (33)
    • cell culture (19)
    • cell product (41)
    • cell separation (6)
    • clinical lab (17)
    • consensus (11)
    • cord blood (12)
    • cytometry (22)
    • direct reprogramming (9)
    • educational (20)
    • embryonic/iPS (63)
    • events (7)
    • gadgets (7)
    • gene transfer (6)
    • hematopoietic (68)
    • interviews (8)
    • lectures (34)
    • mesenchymal (26)
    • methods (27)
    • neural (14)
    • notes (31)
    • open science (24)
    • other adult stem cells (10)
    • protocols (50)
    • RegenMed digest (23)
    • reviews (39)
    • tissue engineering (11)
    • web tools (10)
  • series:

    Experimental bone marrow transplantation 101

    Methods and Protocols Digest

    Mesenchymal Stem Cells – definition and assays

    True Blood - manufacturing blood from stem cells

    RegenMed Digest - industry updates

  • featured posts:

    Discussion: Markers of circulating cancer stem cells – validity and prognostic value

    Current highly ranked articles in stem cell research by Faculty of 1000

    Point-of-care cell processing devices in clinical trials

    The caveats of cell culture for cell therapy

  • polls:

    The next generation of potency assays for hematopoietic graft

    What is the correct name for “mesenchymal stem cells”?

    What is the most promising method for targeting cancer stem cells?

    True blood: What approach is more promising for blood manufacturing?

  • recent comments

    • Bourin on Analysis of the quality of autologous cord blood stored in private banks
    • Jim H on Analysis of the quality of autologous cord blood stored in private banks
    • Alexey Bersenev on Analysis of the quality of autologous cord blood stored in private banks
    • Frances Verter on FDA licenses first cord blood product
    • William Ganely on FDA licenses first cord blood product
  • blogs we recommend:

    Hematopoiesis
    Knoepfler Lab Stem Cell Blog
    Cell Therapy Blog
    Stem Cell Treatment Monitor
    Stem Cell Network Blog
    The Cell Culture Dish

  • popular tags:

    assay BMT model business cancer cancer stem cell CD34 cell culture cell product cell therapy clinical-grade clinical trial collaboration colony assay cord blood direct transdifferentiation discussion embryonic stem cell FACS flow cytometry guidelines HSC HSC isolation iPS jove lecture marker market method MSC MSC isolation neural stem cell open science pluripotency progenitor protocol regenerative medicine RegenMed reprogramming review risk safety stem cell tissue engineering video xeno
  • cell therapy trials tracking:

  • databases:

    Cell Image Library Reference

    Stem Cell Lineage Database

    Characterization Tool

    European Human Embryonic Stem Cell Registry

    PluriTest

    StemBase

    StemDB

  • license:

    Creative Commons License
    This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License.
  • Ads

Get smart with the Thesis WordPress Theme from DIYthemes.

WordPress Admin